Product image of Vyjuvek (Beremagene Geperpavec) supplied by GNH India

Vyjuvek

Active Ingredient:
Beremagene Geperpavec
Origin:
EU

Vyjuvek (Beremagene Geperpavec)

Vyjuvek (beremagene geperpavec) is a topical gene therapy designed for cutaneous use. It is indicated for the treatment of wounds in patients with dystrophic epidermolysis bullosa. This non-invasive option targets the underlying genetic cause of the condition.

Manufacturer / TM Owner

Krystal Biotech Netherlands, B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Vyjuvek is used to treat chronic wounds in adults and children with dystrophic epidermolysis bullosa, a rare genetic skin disorder. It works by delivering functional collagen VII protein to promote wound healing. This gene therapy aims to address the root cause of the condition rather than just managing symptoms. Patients and caregivers often seek options for persistent wounds that do not respond to standard care.

Side Effects

  • When applied to wounds, Vyjuvek may help reduce the size of chronic wounds over time. Users may notice improved skin integrity and faster healing compared to untreated wounds. The effects vary by individual, and consistent application is typically required. Some patients report reduced pain and discomfort in treated areas as wounds begin to close.

Precautions & Warnings

  • Vyjuvek should only be handled by healthcare professionals trained in its application. Avoid direct contact with eyes or mucous membranes during administration. Store the product as directed, typically refrigerated, and protect it from light. Patients with known allergies to any components of the therapy should consult their healthcare provider before use.

Avoid Interactions

  • No specific drug interactions have been widely reported for Vyjuvek. However, patients using other topical treatments on the same wound area should inform their healthcare provider. Combining Vyjuvek with systemic medications, particularly immunosuppressants, may require careful monitoring. Always disclose all medications and treatments to your healthcare team.

Frequently Asked Questions

Vyjuvek is used to treat chronic wounds in patients with dystrophic epidermolysis bullosa.

Vyjuvek is applied directly to wounds by a healthcare professional as a topical gene therapy.

Vyjuvek is indicated for adults and children with dystrophic epidermolysis bullosa who have chronic wounds.

Common effects may include redness or irritation at the application site, but these vary by individual.

Consult a healthcare provider before combining Vyjuvek with other topical or systemic medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Beremagene Geperpavec

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT